Invesco
FLNA

Invesco’s Filana Therapeutics FLNA Stock Holding History

Invesco’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-31,130
Closed -$52.6K – 3920
2026
Q1 		$52.6K Buy
31,130
+13,010
+72% +$26.8K ﹤0.01% 3688
2025
Q4 		$35.9K Buy
+18,120
New +$58K ﹤0.01% 3729
2025
Q2 		– Sell
-13,117
Closed -$19.7K – 3856
2025
Q1 		$19.7K Sell
13,117
-2,291
-15% -$5.78K ﹤0.01% 3744
2024
Q4 		$36.4K Sell
15,408
-290,882
-95% -$5.11M ﹤0.01% 3718
2024
Q3 		$9.01M Buy
306,290
+291,519
+1,974% +$6.71M ﹤0.01% 1895
2024
Q2 		$182K Buy
14,771
+554
+4% +$11.7K ﹤0.01% 3647
2024
Q1 		$288K Sell
14,217
-61,275
-81% -$1.41M ﹤0.01% 3539
2023
Q4 		$1.7M Buy
75,492
+58,679
+349% +$1.24M ﹤0.01% 2677
2023
Q3 		$280K Sell
16,813
-357
-2% -$7.08K ﹤0.01% 3478
2023
Q2 		$421K Sell
17,170
-278,452
-94% -$6.71M ﹤0.01% 3338
2023
Q1 		$7.13M Sell
295,622
-124,668
-30% -$3.45M ﹤0.01% 2042
2022
Q4 		$12.4M Buy
420,290
+164,203
+64% +$5.9M ﹤0.01% 1693
2022
Q3 		$10.7M Buy
256,087
+240,355
+1,528% +$6.49M ﹤0.01% 1746
2022
Q2 		$442K Sell
15,732
-489
-3% -$12.3K ﹤0.01% 3388
2022
Q1 		$602K Sell
16,221
-342
-2% -$14.5K ﹤0.01% 3301
2021
Q4 		$723K Sell
16,563
-1,578
-9% -$82.8K ﹤0.01% 3238
2021
Q3 		$1.13M Sell
18,141
-154,923
-90% -$12.9M ﹤0.01% 3049
2021
Q2 		$14.8M Buy
173,064
+153,686
+793% +$8.23M ﹤0.01% 1806
2021
Q1 		$871K Buy
19,378
+6,921
+56% +$272K ﹤0.01% 3101
2020
Q4 		$85K Buy
+12,457
New +$111K ﹤0.01% 3662
2014
Q4 		– Sell
-2,900
Closed -$79K – 4100
2014
Q3 		$79K Sell
2,900
-4,583
-61% -$139K ﹤0.01% 3901
2014
Q2 		$301K Buy
7,483
+312
+4% +$11.5K ﹤0.01% 3538
2014
Q1 		$277K Buy
+7,171
New +$253K ﹤0.01% 3623

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Invesco's FLNA Position: Q2 2026 in Review

Invesco sold out of Filana Therapeutics (FLNA) in Q2 2026, closing a stake of 31,130 shares — an estimated $52.6K sold.

Invesco first reported a position in FLNA in Q1 2014 and held it in 23 quarters. The position peaked at $14.8M in Q2 2021. 84 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Invesco reported no remaining Filana Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Invesco sold 31,130 Filana Therapeutics shares in Q2 2026, an estimated $52.6K.
  • Invesco first reported a position in Filana Therapeutics in Q1 2014 and held it in 23 quarters.
  • Invesco's Filana Therapeutics position peaked at $14.8M in Q2 2021.
  • 84 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.